Malignant melanoma and Dehydration
Summary:
Dehydration is found among people with Malignant melanoma, especially for people who are male, 60+ old.
The study analyzes which people have Dehydration with Malignant melanoma. It is created by eHealthMe based on reports of 979 people who have Malignant melanoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Malignant melanoma?
Malignant melanoma (skin cancer rises from melancytes) is found to be associated with 790 drugs and 740 conditions by eHealthMe. Check the latest studies of Malignant melanoma.
What is Dehydration?
Dehydration (dryness resulting from the removal of water) is found to be associated with 2,752 drugs and 3,349 conditions by eHealthMe. Check the latest studies of Dehydration.
979 people who have Malignant Melanoma and Dehydration are studied.

Gender of people who have Malignant melanoma and experienced Dehydration *:
Age of people who have Malignant melanoma and experienced Dehydration *:
Common co-existing conditions for these people *:
Common drugs taken by these people *:
Common symptoms for these people *:
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Dehydration?
- Check whether Dehydration is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Malignant melanoma (60,273 reports)
- Dehydration (173,274 reports)
All the drugs that are associated with Dehydration:
- Dehydration (2,752 drugs)
All the conditions that are associated with Dehydration:
- Dehydration (3,349 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Dehydration and Malignant melanoma, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Tacrolimus and Amoxicillin - 3 seconds ago
- Drug interactions of Forteo and Desonide - 6 seconds ago
- Osteoporosis and Neurological Symptom - 7 seconds ago
- Vitamin B2 vs. Axert, side effect and effectiveness comparison - 10 seconds ago
- Could Testosterone Cypionate cause Blood Creatinine Increased? - 10 seconds ago
- Could Creon cause Hepatic Fibrosis? - 12 seconds ago
- Drug interactions of Ceftriaxone and Sennosides - 15 seconds ago
- Could Apixaban cause Multiple Sclerosis? - 19 seconds ago
- Drug interactions of Promethazine and Licorice - 21 seconds ago
- Drug interactions of Senna and Gaviscon - 21 seconds ago